We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fujifilm Launches Droplet-Reduction Mouthpiece to Reduce COVID-19 Risk in Endoscopic Examinations

By HospiMedica International staff writers
Posted on 04 Nov 2020
FUJIFILM Corporation (Tokyo, Japan) has launched a new droplet reduction mouthpiece named B1 to potentially increase safety and reduce risks arising from COVID-19 during endoscopy procedures.

The mouthpiece B1 incorporating a sponge rubber, a droplet reduction accessory, and a drape shield specifically created to catch and reduce the droplets emitted by the patient during endoscopic examination of the upper gastrointestinal tract, helps minimize the risk to healthcare workers and fellow patients from becoming infected with COVID-19 and various other pathogens. More...
The B1 is placed in the patient’s mouth and fixed with a headband. With Fujifilm’s conventional mouthpieces, the endoscope is thus protected from damage. The accessory is easy to handle and does not inconvenience the patient when compared to using a standard mouthpiece. The accessory can be used with different types of endoscopes having various diameters, ensuring that there are no gaps between the endoscope and the mouthpiece.

The B1 also comes with a drape shield for covering the patient's face. It shields healthcare workers from patients during peroral endoscopy, thereby reducing the risk of viral infection by way of droplet transmission. It reduces the spread of aerosol droplets by incorporating sponges which have slits in the insertion part of the mouthpiece where the endoscope is introduced. This design ensures that there are no gaps between the endoscope and the mouthpiece. The mouthpiece is designed with extra depth to create space between the face shield and the patient’s face to maximize air ventilation for the patient. It also reduces discomfort caused by covering the face with the shield. Internal tests have shown that, the B1 cuts more than 99% of respiratory droplets measuring 5μm or larger produced by coughing as compared to Fujifilm's conventional mouthpiece.



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.